Category: calixar
TMPRSS2 usage by SARS-CoV-2 Omicron impacts tropism and fusogenicity
- Benjamin
- 0
Here we show that Omicron spike has higher affinity for ACE2 compared to Delta as well as a marked change of antigenicity conferring significant evasion of therapeutic monoclonal and vaccine-elicited polyclonal neutralising antibodies after two doses. mRNA vaccination as a third vaccine dose rescues and broadens neutralization.Importantly, antiviral drugs remdesivir and molnupiravir retain efficacy against Omicron BA.1.…
Read Morecovid 19 Diagnosis test series
- Benjamin
- 0
CDC has developed two laboratory tests that identify SARS-CoV-2, the virus that causes COVID-19. The first test for COVID-19 diagnosis that CDC distributed, released in February 2020, is the CDC 2019-Novel Coronavirus (2019-nCoV) Real-Time RT-PCR Diagnostic Panel, a test that accurately detects SARS-CoV-2 in respiratory specimens. CDC released a second assay in July 2020, the…
Read Moreself test all allergies
- Benjamin
- 0
Measures your body’s Immunoglobulin E (IgE) antibody reactivity to 40 common indoor and outdoor allergens Your test results will report your IgE reactivity from very low to very high, with advice about possible next steps. This information is a helpful step toward understanding which suspected allergens may be causing unwanted symptoms, so you can better…
Read MoreImmunemed leptospira rapid
- Benjamin
- 0
Abstract Background Leptospirosis is often misdiagnosed with several other tropical febrile illnesses in Malaysia due to similarities in clinical manifestations. Although treatment regimens could be started based on clinical judgments, early diagnosis has become paramount as a guide to chemotherapeutic interventions. Confirmed laboratory diagnosis through MAT or PCR is time consuming and usually available only in reference laboratories…
Read More